Cubed Biotech Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $500K

  • Investors
  • 1

Cubed Biotech General Information

Description

Operator of a biotech firm intended to manufacture natural multi-psychedelic medicines. The company's platform cultivates, extracts, purify & synthesize natural entheogens (i.e., psilocybin from mushrooms, mescaline from cacti, and ayahuasca's DMT and monoamine oxidase inhibitors) such as mushrooms, cacti, and ayahuasca for mental health and addiction issues, it is federally licensed to develop, manufacture, and commercialize psychedelic medicine to unnerve the current treatments of mental illness & addiction, enabling patients suffering from depression and anxiety to get relief from all of their mental health disorders.

Contact Information

Formerly Known As
Cubed (Drug Discovery)
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 275 Kesmark
  • Dollard-des Ormeaux, Quebec H9B 3J1
  • Canada
+1 (514)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 275 Kesmark
  • Dollard-des Ormeaux, Quebec H9B 3J1
  • Canada
+1 (514)

Cubed Biotech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cubed Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 15-Jan-2025 $500K Completed Generating Revenue
5. Later Stage VC 01-Mar-2024 Completed Generating Revenue
4. Later Stage VC (Series C) Completed Generating Revenue
3. Early Stage VC (Series B) Completed Generating Revenue
2. Equity Crowdfunding 09-Jun-2022 $2.33M $2.73M Completed Generating Revenue
1. Seed Round 07-Jul-2021 $400K $400K Completed Startup
To view Cubed Biotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cubed Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cubed Biotech Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
VentureCrowd Venture Capital Minority
To view Cubed Biotech’s complete investors history, request access »

Cubed Biotech FAQs

  • When was Cubed Biotech founded?

    Cubed Biotech was founded in 2020.

  • Where is Cubed Biotech headquartered?

    Cubed Biotech is headquartered in Dollard-des Ormeaux, Canada.

  • What is the size of Cubed Biotech?

    Cubed Biotech has 8 total employees.

  • What industry is Cubed Biotech in?

    Cubed Biotech’s primary industry is Drug Discovery.

  • Is Cubed Biotech a private or public company?

    Cubed Biotech is a Private company.

  • What is Cubed Biotech’s current revenue?

    The current revenue for Cubed Biotech is .

  • How much funding has Cubed Biotech raised over time?

    Cubed Biotech has raised $11.8M.

  • Who are Cubed Biotech’s investors?

    VentureCrowd has invested in Cubed Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process